Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogene expression in mammary epithelial cells.

B Groner1

  • 1Friedrich Miescher Institute, Basel, Switzerland.

Journal of Cellular Biochemistry
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib.

MedChemComm·2018
Same author

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.

Leukemia·2017
Same author

c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.

Oncogene·2011
Same author

Direction of the recognition specificity of cytotoxic T cells toward tumor cells by transduced, chimeric T-cell receptor genes.

Methods in molecular medicine·2011
Same author

A sparing procedure to clear the mouse mammary fat pad of epithelial components for transplantation analysis.

Laboratory animals·2008
Same author

Cooperation of nuclear transcription factors regulated by steroid and peptide hormones.

Ernst Schering Research Foundation workshop·2002

Transgenic mouse models with defined genetic alterations develop tumors similar to human cancers. Oncogene expression in mammary cells drives tumor development, with varying potential and synergistic effects influencing cancer progression.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • High-incidence mouse tumor models mimicking human cancers have been developed.
  • Tumors arise from specific genetic alterations within the mouse genome.
  • Research integrates human tumor molecular analysis, gene regulatory elements, and transgenic technologies.

Purpose of the Study:

  • To investigate the role of oncogenes in mammary tumor development using transgenic mouse models.
  • To understand the oncogenic potential and synergistic effects of specific genes in carcinogenesis.
  • To explore the implications for multistep carcinogenesis models.

Main Methods:

  • Development of transgenic mouse strains through microinjection of recombinant DNA into fertilized eggs.
  • Introduction of specific oncogenes and tumor suppressor genes into the mouse genome.

Related Experiment Videos

  • Analysis of mammary epithelial cell gene expression and tumor formation.

    • Main Results:

    • Expression of oncogenes in mammary gland cells predisposes mice to mammary tumors.
    • Different oncogenes exhibit varying oncogenic potential in mammary epithelial cells.
    • Oncogene expression can induce preneoplastic states, affecting cell growth and differentiation.
    • Synergistic effects between oncogenes and with physiological signals (e.g., estrogen) reduce tumor latency.

    Conclusions:

    • Transgenic mouse models provide valuable platforms for studying human cancer genetics.
    • Oncogene expression is a critical driver of mammary carcinogenesis.
    • Multistep carcinogenesis involves complex interactions between genetic alterations and cellular processes.